Navigation Links
STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
Date:10/27/2009

MONROVIA, Calif., Oct. 27 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA) today announced that it will release financial results for the third quarter ended September 30, 2009 on Monday, November 2, 2009 after the market close. The Company will host a conference call and webcast on Tuesday, November 3, 2009 at 10:00 a.m. Eastern / 7:00 a.m. Pacific to discuss the Company's third quarter results and current corporate developments. The timing of the release and call results from management's schedule and recent invitation to present at the Oppenheimer & Co. conference on Wednesday, November 4. The dial-in number for the conference call is 877-941-2927 for domestic participants and 480-629-9725 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4169709#. To access the live webcast of the call, go to STAAR's website at www.staar.com. An archived webcast will also be available at www.staar.com.

About STAAR Surgical

STAAR is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
2. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
4. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
5. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
6. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
7. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
8. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
9. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
10. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
11. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 Pharma ... new infographic summary of the results from an ... third of all respondents stated that CROs would be an ... of respondents will be running 6 or more clinical trials ... the Clinical Trial Supply USA Summit ...
(Date:6/18/2013)... 19, 2013 , Safinamide ... (PD) patients as add-on to levodopa ... motor symptoms in fluctuating PD patients as add-on ... Pharmaceuticals S.p.A. ("Newron"), a research and development company ... its partner Zambon S.p.A., a pharmaceutical company strongly ...
(Date:6/18/2013)... June 18, 2013 Valeant Pharmaceuticals International, Inc. ... priced its previously announced public offering of common shares ... issue 23,529,412 common shares at a price of $85.00 ... billion. The Company will file a final prospectus supplement ... and will make a similar filing with the securities ...
Breaking Medicine Technology:Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4
... 13, 2011 Champions Oncology, Inc. formerly Champions Biotechnology, ... Fiscal Year 2012 First Quarter Financial Results:Total operating ... $1.63 million compared to $1.60 million in the first ... first quarter of fiscal 2012 were $3.85 million compared ...
... Sept. 13, 2011 IMD Companies, Inc., (OTC Markets ... The company acquired the brand from Healthy America Inc., ... April 25, 2011 following a vote of the shareholders ... company also assumed the liabilities of HAI in the ...
Cached Medicine Technology:Champions Oncology Reports Fiscal 2012 First Quarter Financial Results 2Champions Oncology Reports Fiscal 2012 First Quarter Financial Results 3Champions Oncology Reports Fiscal 2012 First Quarter Financial Results 4Champions Oncology Reports Fiscal 2012 First Quarter Financial Results 5IMD Announces the Acquisition of the Kidshape® Brand 2
(Date:6/19/2013)... system for repairing damage to the genetic material DNA ... may seem, those compounds are sparking optimism as potential ... mutation in BRCA, a gene that made headlines when ... compounds, termed PARP inhibitors, are the topic of the ... & Engineering News . C&EN is the weekly news ...
(Date:6/19/2013)... Dental professionals are increasingly monitoring end tidal carbon ... sedation, a patient’s breathing depth and rate decrease. ... to update its guidelines to require etCO2 monitoring, or ... to increase safety in procedures. This amendment to Section ... effect July 1. , The Oregon Board of ...
(Date:6/19/2013)... DiscountFurnaceFilter.com, the number one solution for homeowner’s ... Compressor Saver kit at an exceptional price. The 5-2-1 Compressor ... air conditioning unit during start up, saving wear and tear ... unit burn out. , The 5-2-1 Compressor Saver ... uses less power to start and drastically reduces the rush ...
(Date:6/19/2013)... Scottsdale, AZ (PRWEB) June 19, 2013 Guests ... feel healthy, wealthy and wise even if they don’t go ... that does require some early thought. , ... pockets when they take advantage of the pet-friendly Scottsdale Paradise ... Percent Package . With at least 14 days advance notice, ...
(Date:6/19/2013)... Washington (PRWEB) June 19, 2013 ... physicians deem it medically necessary, according to a ... and Child Health Journal. The results of this ... for more than a decade – that trying-to-conceive ... and maintaining a healthy body weight. Fairhaven Health ...
Breaking Medicine News(10 mins):Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4
... , THURSDAY, Aug. 11 (HealthDay News) -- The HIV ... a high prevalence of AIDS is 10 to 20 times ... government report indicates. Two percent of poor heterosexuals in ... Disease Control and Prevention researchers, analysis of National HIV Behavioral ...
... Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) has awarded ... the University Hospitals (UH) Neuromuscular Center in Northeast Ohio. ... in Cleveland, Oh., UH Ahuja Medical Center in Beachwood, ... Oh., and UH Westlake Health Center in Westlake, Oh., ...
... According to a study published in ... Society of Hematology (ASH), researchers have reported that administration ... cells from the bone marrow into the blood, is unlikely ... development of abnormalities involving loss or gains of chromosomes that ...
... -- There,s no strong evidence that taking aspirin while ... of becoming pregnant, researchers say. Routine use of ... aspirin may improve blood flow to the womb and ... cause pregnancy complications or miscarriage. To ...
... Aug. 11 (HealthDay News) -- Symptoms of Alzheimer,s disease ... according to a new study that examined the relationship ... The study included 105 Alzheimer,s patients and 125 dementia-free ... to 75 (young-old) and those 80 and older (very ...
... , THURSDAY, Aug. 11 (HealthDay News) -- The ... with a high prevalence of AIDS is 10 to 20 ... government report indicates. Two percent of poor heterosexuals ... for Disease Control and Prevention researchers, analysis of National HIV ...
Cached Medicine News:Health News:Poor, Urban Heterosexuals at High Risk of HIV: CDC 2Health News:Stem cell mobilization therapy found to be safe for bone marrow donors 2Health News:Stem cell mobilization therapy found to be safe for bone marrow donors 3Health News:Alzheimer's Harder to Detect in the Very Old 2
Containing more than 600 full drug monographs, plus abbreviated monographs for combination drugs, orphan drugs and AIDS drugs in development, A to Z Drug Facts provides up-to-date information on more...
Provides instant access to reliable information on herbs, minerals, vitamins, amino acids, probiotics, enzymes, over-the-counter hormones, and other dietary supplements commonly used by consumers....
Updated for 2006 with more than 800 complete drug entries, this mobile reference provides instant access to all the drug information nurses need in day-to-day practice....
... The Quality Module QS I evaluates ... of centrifuged serum samples. The System ... and recognizes if a sample contains ... with the Aliquoting System RSD 800A ...
Medicine Products: